Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease

被引：47

作者：

Rana, JS ^{[1
]}

Mannam, A

Donnell-Fink, L

Gervino, EV

Sellke, FW

Laham, RJ

机构：

[1] Harvard Univ, Sch Med, Angiogenesis Res Ctr, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Dept Med, Div Cardiol & Cardiac Surg, Boston, MA 02115 USA

[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 95卷 / 12期

关键词：

D O I：

10.1016/j.amjcard.2005.02.013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The long-term beneficial effects of placebo therapy were evaluated in angiogenesis and laser myocardial revascularization trials in patients who had end-stage coronary heart disease. Improvements in mean angina class, exercise treadmill time, and quality of life were mostly maintained at 30 +/- 6 months of follow-up. Persistence of effect cannot be used as evidence or efficacy, and double-blinded trials are essential in this patient population. (c) 2005 by Excerpta Medica Inc.

引用

页码：1456 / 1459

页数：4

共 12 条

[1] Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease [J].

Bush, MA ;

Samara, E ;

Whitehouse, MJ ;

Yoshizawa, C ;

Novicki, DL ;

Pike, M ;

Laham, RJ ;

Simons, M ;

Chronos, NA .

JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (04) :378-385

[2] Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index Cardiac Version III [J].

Dougherty, CM ;

Dewhurst, T ;

Nichol, WP ;

Spertus, J .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (07) :569-575

[3] Angiographic methods to assess human coronary angiogenesis [J].

Gibson, CM ;

Ryan, K ;

Sparano, A ;

Moynihan, JL ;

Rizzo, M ;

Kelley, M ;

Marble, SJ ;

Laham, R ;

Simons, M ;

McClusky, TR ;

Dodge, JT .

AMERICAN HEART JOURNAL, 1999, 137 (01) :169-179

[4] Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease [J].

Henry, TD ;

Rocha-Singh, K ;

Isner, JM ;

Kereiakes, DJ ;

Giordano, FJ ;

Simons, M ;

Losordo, DW ;

Hendel, RC ;

Bonow, RO ;

Eppler, SM ;

Zioncheck, TF ;

Holmgren, EB ;

McCluskey, ER .

AMERICAN HEART JOURNAL, 2001, 142 (05) :872-880

[5] Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping [J].

Kornowski, R ;

Baim, DS ;

Moses, JW ;

Hong, MK ;

Laham, RJ ;

Fuchs, S ;

Hendel, RC ;

Wallace, D ;

Cohen, DJ ;

Bonow, RO ;

Kuntz, RE ;

Leon, MB .

CIRCULATION, 2000, 102 (10) :1120-1125

[6] Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study [J].

Laham, RJ ;

Chronos, NA ;

Pike, M ;

Leimbach, ME ;

Udelson, JE ;

Pearlman, JD ;

Pettigrew, RI ;

Whitehouse, MJ ;

Yoshizawa, C ;

Simons, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2132-2139

[7] Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization [J].

Laham, RJ ;

Simons, M ;

Pearlman, JD ;

Ho, KKL ;

Baim, DS .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (01) :1-8

[8] Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery - Results of a phase I randomized, double-blind, placebo-controlled trial [J].

Laham, RJ ;

Sellke, FW ;

Edelman, ER ;

Pearlman, JD ;

Ware, JA ;

Brown, DL ;

Gold, JP ;

Simons, M .

CIRCULATION, 1999, 100 (18) :1865-1871

[9] Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial [J].

Lederman, RJ ;

Mendelsohn, FO ;

Anderson, RD ;

Saucedo, JF ;

Tenaglia, AN ;

Hermiller, JB ;

Hillegass, WB ;

Rocha-Singh, K ;

Moon, TE ;

Whitehouse, MJ ;

Annex, BH .

LANCET, 2002, 359 (9323) :2053-2058

[10] Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein [J].

Ruel, M ;

Laham, RJ ;

Parker, JA ;

Post, MJ ;

Ware, JA ;

Simons, M ;

Sellke, FW .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 124 (01) :28-34

← 1 2 →